Literature DB >> 26307099

A "universal" model of metastatic cancer, its parametric forms and their identification: what can be learned from site-specific volumes of metastases.

Leonid Hanin1, Karen Seidel2, Dietrich Stoevesandt3.   

Abstract

We develop a methodology for estimating unobservable characteristics of the individual natural history of metastatic cancer from the volume of the primary tumor and site-specific volumes of metastases measured before, or shortly after, the start of treatment. In particular, we address the question as to what information about natural history of cancer can and cannot be gained from this type of data. Estimation of the natural history of cancer is based on parameterization of a very general mathematical model of cancer progression accounting for primary tumor growth, shedding of metastases, their selection, latency and growth in a given secondary site. This parameterization assumes Gompertz (and, as a limiting case, exponential) growth of the primary tumor, exponential growth of metastases, and exponential distribution of metastasis latency times. We find identifiable parameters of this model and give a rigorous proof of their identifiability. As an illustration, we analyze a clinical case of renal cancer patient who developed 55 lung metastases whose volumes were measured through laborious reading of CT images. The model with maximum likelihood parameters provided an excellent fit to this data. We uncovered many aspects of this patient's cancer natural history and showed that, according to the model, onset of metastasis occurred long before primary tumor became clinically detectable.

Entities:  

Keywords:  Exponential tumor growth; Gompertz law of tumor growth; Metastatic latency; Model identifiability; Natural history of cancer; Poisson process

Mesh:

Year:  2015        PMID: 26307099     DOI: 10.1007/s00285-015-0928-6

Source DB:  PubMed          Journal:  J Math Biol        ISSN: 0303-6812            Impact factor:   2.259


  15 in total

1.  Breast cancer stem cells revealed.

Authors:  John E Dick
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-25       Impact factor: 11.205

2.  Prospective identification of tumorigenic prostate cancer stem cells.

Authors:  Anne T Collins; Paul A Berry; Catherine Hyde; Michael J Stower; Norman J Maitland
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

3.  Proceedings: Tumor angiogenesis factor.

Authors:  J Folkman
Journal:  Cancer Res       Date:  1974-08       Impact factor: 12.701

Review 4.  Concomitant tumor immunity and the resistance to a second tumor challenge.

Authors:  E Gorelik
Journal:  Adv Cancer Res       Date:  1983       Impact factor: 6.242

Review 5.  Laboratory and clinical research in breast cancer--a personal adventure: the David A. Karnofsky memorial lecture.

Authors:  B Fisher
Journal:  Cancer Res       Date:  1980-11       Impact factor: 12.701

Review 6.  Seeing the invisible: how mathematical models uncover tumor dormancy, reconstruct the natural history of cancer, and assess the effects of treatment.

Authors:  Leonid Hanin
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 7.  From Halsted to prevention and beyond: advances in the management of breast cancer during the twentieth century.

Authors:  B Fisher
Journal:  Eur J Cancer       Date:  1999-12       Impact factor: 9.162

8.  Reconstruction of the natural history of metastatic cancer and assessment of the effects of surgery: Gompertzian growth of the primary tumor.

Authors:  Leonid Hanin; Svetlana Bunimovich-Mendrazitsky
Journal:  Math Biosci       Date:  2013-11-06       Impact factor: 2.144

9.  Does extirpation of the primary breast tumor give boost to growth of metastases? Evidence revealed by mathematical modeling.

Authors:  Leonid Hanin; Olga Korosteleva
Journal:  Math Biosci       Date:  2009-11-20       Impact factor: 2.144

Review 10.  Human renal cancer stem cells.

Authors:  Benedetta Bussolati; Benjamin Dekel; Bruno Azzarone; Giovanni Camussi
Journal:  Cancer Lett       Date:  2012-05-12       Impact factor: 8.679

View more
  2 in total

1.  Practical identifiability analysis of a mechanistic model for the time to distant metastatic relapse and its application to renal cell carcinoma.

Authors:  Arturo Álvarez-Arenas; Wilfried Souleyreau; Andrea Emanuelli; Lindsay S Cooley; Jean-Christophe Bernhard; Andreas Bikfalvi; Sebastien Benzekry
Journal:  PLoS Comput Biol       Date:  2022-08-25       Impact factor: 4.779

2.  In silico modeling for tumor growth visualization.

Authors:  Fleur Jeanquartier; Claire Jean-Quartier; David Cemernek; Andreas Holzinger
Journal:  BMC Syst Biol       Date:  2016-08-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.